BioCryst Pharmaceuticals ...

7.86
0.03 (0.38%)
At close: Mar 28, 2025, 3:59 PM
7.82
-0.47%
After-hours: Mar 28, 2025, 06:21 PM EDT

BioCryst Pharmaceuticals Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95 FY94
Revenue 450.71M 331.41M 270.83M 157.17M 17.81M 48.84M 20.65M 25.19M 26.35M 48.26M 13.61M 17.33M 26.29M 19.64M 63.5M 74.59M 56.56M 71.24M 6.21M 151.87K 336.9K 1.63M 1.77M 11.16M 3.32M 2.5M 6.4M 1M 2.7M 200K 700K
Cost of Revenue 12.27M 4.66M 6.59M 7.26M 1.68M 4.1M 471K 1.7M 2.7M 1.9M 122K 98K 132K n/a 86K 4.54M n/a n/a n/a n/a n/a n/a n/a n/a n/a -500K -500K -600K 7.1M 6.5M 5M
Gross Profit 438.44M 326.75M 264.23M 149.91M 16.14M 44.73M 20.18M 23.48M 23.65M 46.36M 13.49M 17.23M 26.16M 19.64M 63.41M 70.05M 56.56M 71.24M 6.21M 151.87K 336.9K 1.63M 1.77M 11.16M 3.32M 3M 6.9M 1.6M -4.4M -6.3M -4.3M
Operating Income -2.54M -103.71M -148.44M -177.72M -174.76M -99.45M -94.22M -57.41M -48.61M -39.44M -45.77M -30.72M -33.89M -49.59M -33.24M -13.74M -27.16M -32.28M -46.98M -27.18M -21.75M -12.7M -16.55M -4.99M -9.83M -8.1M -6M -12.3M -7.6M -9.1M -6.8M
Interest Income 14.75M 15.78M 5.13M 62K 9.42M 1.93M 2.25M 1.01M 793K 535K 93K 93K 222K 413K 503.54K 285.69K 2.43M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income -86.95M -226.23M -244.38M -181.81M -182.81M -108.9M -101.25M -65.78M -55.14M -43.02M -45.19M -30.11M -39.08M -56.95M -33.85B -13.45M -24.73M -29.05M -26.1B -26.1B -21.1B -12.7B -16.93B -4.99B -11.58B -6.9M -4.7M -10.6M n/a -8.4M n/a
Net Income -88.88M -226.54M -247.12M -184.06M -196.57M -120.06M -101.25M -65.78M -55.14M -43.02M -45.19M -30.11M -39.08M -56.95M -32.73M -13.45M -24.73M -29.06M -43.62M -26.1M -21.1M -12.7M -16.93M -4.99M -11.58M -5.3M -4.8M -10.6M -7.7M -8.6M -6.9M
Selling & General & Admin 266.13M 213.89M 159.37M 118.82M 67.93M 37.12M 29.51M 13.93M 11.25M 13.05M 7.46M 5.22M 6.83M 12.33M 14.18M 11.48M 10.4M 9.47M 6.11M 3.69M 3.21M 2.81M 2.86M 3.05M 3.56M 2.9M 3.1M 2.7M 2.7M 2.2M 1.9M
Research & Development 174.64M 216.57M 253.3M 208.81M 122.96M 107.07M 84.89M 66.96M 61.01M 72.76M 51.8M 42.73M 51.46M 56.9M 82.47M 72.3M 73.33M 94.05M 47.08M 23.64M 18.87M 11.52M 15.47M 13.09M 9.59M 7.7M 9.3M 10.6M n/a n/a n/a
Other Expenses 216K n/a 253.27M 202.92M 111.96M 82.44M 70.81M 54.38M 47.01M 33.71M 41.37M 28.06M 30.38M 37.26M n/a n/a n/a n/a n/a n/a 8.34K n/a n/a n/a n/a 500K 500K 600K 500K 600K 600K
Operating Expenses 440.99M 430.46M 412.67M 327.63M 190.89M 144.19M 114.4M 80.89M 72.26M 85.81M 59.26M 47.95M 58.29M 69.23M 96.65M 83.78M 83.73M 103.52M 53.19M 27.33M 22.09M 14.33M 18.33M 16.14M 13.15M 11.1M 12.9M 13.9M 3.2M 2.8M 2.5M
Interest Expense 98.52M 108.24M 99.09M 59.29M 14.5M 11.89M 9.18M 8.56M 6.49M 5.2M 5M 4.78M 4.67M 3.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a 14.4M 14.89M 5.71M 6.57M n/a n/a n/a n/a n/a n/a n/a n/a n/a 419.00 -187 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 453.25M 435.12M 419.26M 334.89M 192.57M 148.29M 114.87M 82.6M 74.96M 87.7M 59.38M 48.05M 58.42M 69.23M 96.74M 88.33M 83.73M 103.52M 53.19M 27.33M 22.09M 14.33M 18.33M 16.14M 13.15M 10.6M 12.4M 13.3M 10.3M 9.3M 7.5M
Income Tax 1.93M 310K 2.73M 2.25M 13.75M 11.17M 2.14M 7.86M 6M 5.02M 4.82M 4.47M 4.04M 6.47M 500.76M -1.61M -430 524.00 -26.06B 1.08B -647.75K -12.69B 373.9K -4.98B -11.57B -2.8M -1.2M -1.7M 100K -500K 100K
Shares Outstanding (Basic) 206.7M 192.2M 185.91M 179.12M 167.27M 115.6M 103.19M 84.45M 73.7M 72.9M 66.77M 55.22M 49.47M 45.14M 44.56M 38.93M 38.06M 32.77M 29.15M 25.72M 21.17M 17.7M 17.64M 17.56M 17.47M 15.38M 14.12M 13.78M 11.16M 8.96M 6.76M
Shares Outstanding (Diluted) 206.7M 192.2M 185.91M 179.12M 167.27M 115.6M 103.19M 84.45M 73.7M 72.9M 66.77M 55.22M 49.47M 45.14M 44.56M 38.93M 38.06M 32.77M 29.15M 25.72M 21.17M 17.7M 17.64M 17.56M 18.96M 15.38M 14.12M 13.78M 11.16M 8.96M 6.76M
EPS (Basic) -0.43 -1.18 -1.33 -1.03 -1.18 -1.04 -0.98 -0.78 -0.75 -0.59 -0.68 -0.55 -0.79 -1.26 -0.73 -0.35 -0.65 -0.89 -1.5 -1.01 -1 -0.72 -0.96 -0.28 -0.66 -0.34 -0.34 -0.77 -0.69 -0.96 -1.02
EPS (Diluted) -0.43 -1.18 -1.33 -1.03 -1.18 -1.04 -0.98 -0.78 -0.75 -0.59 -0.68 -0.55 -0.79 -1.26 -0.73 -0.35 -0.65 -0.89 -1.5 -1.01 -1 -0.72 -0.96 -0.28 -0.61 -0.34 -0.34 -0.77 -0.69 -0.96 -1.02
EBITDA 12.81M -116.33M -143.85M -121.74M -167.56M -96.28M -90.36M -56.51M -48.17M -37.64M -40.01M -25.03M -33.79M -52.29M -31.59M -11.84M -23.11M -27.69M -42.8M -25.23M -20.13M -12.58M -17.46M -3.94M -9.16M -7.6M -5.5M -11.7M -8.2M -8.5M -6.2M
Depreciation & Amortization 1.25M 1.66M 1.44M 777K 748K 724K 770K 704K 483K 180K 177K 304K 628K 886K 2.27M 1.61M 1.63M 1.37M 821.2K 864.57K 969.45K 1.1M 1.25M 1.05M 669.21K 500K 500K 600K 500K 600K 600K